CRISPR makes prostate cancer vulnerable to immunotherapy

Per ScienceDaily, scientists have used CRISPR to modify prostate cancer cells, making them easier for the immune system to recognize and destroy. The technique dramatically boosted immunotherapy's effectiveness in mice. This approach may help overcome resistance in other hard-to-treat cancers.

Listen to this story

Hear this and more stories in a personalized audio briefing.

Open The Chonkerton